Related Experiment Videos
Platelet-activating factor effects on bovine pulmonary artery endothelial cells
Circulation Research
|September 1, 1987
Summary
Platelet-activating factor (PAF) alters endothelial cell shape and function by stimulating phosphoinositide turnover. PAF and PMA desensitize beta-adrenergic receptors in endothelial cells, likely through C kinase phosphorylation.
Area of Science:
- Endothelial cell biology
- Cell signaling
- Pharmacology
Background:
- Endothelial cells (ECs) form a cobblestone monolayer in culture.
- Platelet-activating factor (PAF) is a signaling molecule known to affect various cell types.
- Phorbol-12-myristate-13-acetate (PMA) is a potent activator of protein kinase C.
Purpose of the Study:
- To investigate the effects of PAF on endothelial cell morphology and function.
- To elucidate the signaling pathways involved in PAF's action on ECs.
- To assess the impact of PAF on beta-adrenergic receptor activity in ECs.
Main Methods:
- Isolation and culture of bovine pulmonary artery ECs.
- Stimulation of ECs with PAF and PMA.
- Measurement of phosphoinositide turnover and inositol phosphate release.
- Assay of beta-adrenergic receptor-coupled adenylate cyclase activity.
- Analysis of prostacyclin and thromboxane release.
Main Results:
- PAF induced significant changes in EC shape from polygonal to spindle-like.
- PAF stimulated phosphoinositide turnover in ECs with a half-maximal activation at 10(-9) M.
- Preincubation with PAF or PMA decreased adenylate cyclase activity by 70% and 90%, respectively.
- Both PAF and PMA exposure lowered the affinity for isoproterenol threefold.
Conclusions:
- PAF triggers intracellular signaling cascades in ECs, involving Ca2+ and protein kinase C.
- PAF interaction with ECs leads to apparent beta-adrenergic receptor desensitization.
- This desensitization mechanism likely involves C kinase-mediated phosphorylation.